CURATIS N AG (CURN) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.024x

Based on the latest financial reports, CURATIS N AG (CURN) has a cash flow conversion efficiency ratio of -0.024x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-1.05 Million ≈ $-1.33 Million USD) by net assets (CHF44.56 Million ≈ $56.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CURN days of operational coverage to measure how many days the company can operate on defensive assets alone.

CURATIS N AG - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how CURATIS N AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CURATIS N AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CURATIS N AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kino Indonesia Tbk PT JK:KINO	0.101x
Sarla Performance Fibers Limited NSE:SARLAPOLY	0.091x
Frontier Lithium Inc V:FL	0.266x
BIOCELTIX S.A. ZY -10 F:XI3	-0.062x
Big River Industries Ltd AU:BRI	0.084x
Woorim Machinery Co. Ltd KQ:101170	-0.035x
SYNergy ScienTech Corp TW:6558	0.013x
Garuda Indonesia Persero Tbk JK:GIAA	-0.041x

Annual Cash Flow Conversion Efficiency for CURATIS N AG (2002–2024)

The table below shows the annual cash flow conversion efficiency of CURATIS N AG from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see market value of CURATIS N AG.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CHF45.60 Million ≈ $57.65 Million	CHF-825.00K ≈ $-1.04 Million	-0.018x	-100.30%
2023-12-31	CHF-312.00K ≈ $-394.45K	CHF-1.89 Million ≈ $-2.38 Million	6.042x	+976.84%
2022-12-31	CHF6.75 Million ≈ $8.54 Million	CHF-4.65 Million ≈ $-5.88 Million	-0.689x	-176.77%
2021-12-31	CHF-400.00K ≈ $-505.71K	CHF-359.00K ≈ $-453.87K	0.898x	-38.98%
2020-12-31	CHF-257.00K ≈ $-324.92K	CHF-378.00K ≈ $-477.89K	1.471x	+22.64%
2019-12-31	CHF-552.00K ≈ $-697.88K	CHF-662.00K ≈ $-836.95K	1.199x	+160.36%
2018-12-31	CHF377.00K ≈ $476.63K	CHF-749.00K ≈ $-946.94K	-1.987x	-7596.73%
2017-12-31	CHF4.68 Million ≈ $5.92 Million	CHF124.00K ≈ $156.77K	0.027x	+273.50%
2016-12-31	CHF5.04 Million ≈ $6.37 Million	CHF-77.00K ≈ $-97.35K	-0.015x	+23.75%
2015-12-31	CHF6.24 Million ≈ $7.89 Million	CHF-125.00K ≈ $-158.03K	-0.020x	-34.08%
2014-12-31	CHF7.90 Million ≈ $9.99 Million	CHF-118.00K ≈ $-149.18K	-0.015x	+92.26%
2013-12-31	CHF8.71 Million ≈ $11.01 Million	CHF-1.68 Million ≈ $-2.12 Million	-0.193x	-445.52%
2012-12-31	CHF11.60 Million ≈ $14.67 Million	CHF648.00K ≈ $819.25K	0.056x	+32.82%
2011-12-31	CHF7.16 Million ≈ $9.05 Million	CHF301.00K ≈ $380.55K	0.042x	-82.42%
2010-12-31	CHF6.98 Million ≈ $8.82 Million	CHF1.67 Million ≈ $2.11 Million	0.239x	+41.54%
2009-12-31	CHF5.88 Million ≈ $7.44 Million	CHF994.00K ≈ $1.26 Million	0.169x	+105.69%
2008-12-31	CHF1.64 Million ≈ $2.08 Million	CHF-4.88 Million ≈ $-6.16 Million	-2.968x	+90.51%
2007-12-31	CHF227.00K ≈ $286.99K	CHF-7.10 Million ≈ $-8.98 Million	-31.282x	-10014.42%
2006-12-31	CHF9.30 Million ≈ $11.76 Million	CHF-2.88 Million ≈ $-3.64 Million	-0.309x	-27.63%
2005-12-31	CHF21.67 Million ≈ $27.40 Million	CHF-5.25 Million ≈ $-6.64 Million	-0.242x	-801.22%
2004-12-31	CHF37.30 Million ≈ $47.16 Million	CHF1.29 Million ≈ $1.63 Million	0.035x	+188.13%
2003-12-31	CHF49.83 Million ≈ $63.00 Million	CHF-1.95 Million ≈ $-2.47 Million	-0.039x	+89.09%
2002-12-31	CHF55.33 Million ≈ $69.96 Million	CHF-19.88 Million ≈ $-25.13 Million	-0.359x	--

About CURATIS N AG

SW:CURN Switzerland Drug Manufacturers - Specialty & Generic

Market Cap

$153.06 Million

CHF121.06 Million CHF

Market Cap Rank

#19709 Global

#190 in Switzerland

Share Price

CHF23.50

Change (1 day)

-3.29%

52-Week Range

CHF10.45 - CHF26.00

All Time High

CHF891.52